Aslan Pharmaceuticals Ltd Stock Ownership - Who owns Aslan Pharmaceuticals?

Insider buying vs selling

Have Aslan Pharmaceuticals Ltd insiders been buying or selling?
No trades
There has been no insiders buying vs selling in the past 12 months.

Be the first to know when ASLN insiders and whales buy or sell their stock.

ASLN Shareholders

What type of owners hold Aslan Pharmaceuticals Ltd stock?
Bvf Inc0.22%1,049,999$492.45kInstitution
Velan Capital Investment Management LP0.13%625,000$293.13kInstitution
Shay Capital LLC0.09%400,000$187.60kInstitution
Sio Capital Management LLC0.05%254,150$119.20kInstitution
Schonfeld Strategic Advisors LLC0.03%147,400$69.13kInstitution
Renaissance Technologies LLC0.03%122,505$57.45kInstitution
Citadel Advisors LLC0.02%96,604$45.31kInstitution
Adar1 Capital Management LLC0.01%59,393$27.86kInstitution
Fny Investment Advisers LLC0.01%46,700$21.90kInstitution
Millennium Management LLC0.01%39,641$18.59kInstitution

1 of 3

ASLN vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
BRTX0.38%99.62%Net BuyingNet Selling
VCNX4.32%95.68%Net BuyingNet Buying
EFTR1.86%98.14%Net SellingNet Buying
CHRO4.37%48.62%Net Buying

Aslan Pharmaceuticals Stock Ownership FAQ

Who owns Aslan Pharmaceuticals?

Aslan Pharmaceuticals (NASDAQ: ASLN) is owned by 0.64% institutional shareholders, 0.00% Aslan Pharmaceuticals insiders, and 99.36% retail investors. Bvf Inc is the largest individual Aslan Pharmaceuticals shareholder, owning 1.05M shares representing 0.22% of the company. Bvf Inc's Aslan Pharmaceuticals shares are currently valued at $492.45k.

If you're new to stock investing, here's how to buy Aslan Pharmaceuticals stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.